Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M

GLIA

Volumn 63, Issue 1, 2015, Pages 132-141

  Hsu, Meng Ping ^a   Frausto, Ricardo ^a   Rose John, Stefan ^b   Campbell, Iain L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Gp130; Receptor; Signal transducers and activators of transcription; Signal transduction

Indexed keywords

GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MESSENGER RNA; NITRITE; ONCOSTATIN M; ONCOSTATIN M RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN; B-CELL DIFFERENTIATION FACTOR RECEPTOR; INTERLEUKIN 6 RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL SPECIFICITY; CONTROLLED STUDY; IN VITRO STUDY; MACROGLIA; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; C57BL MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; ASTROCYTES; INTERLEUKIN-6; MICE, INBRED C57BL; MICROGLIA; ONCOSTATIN M; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, INTERLEUKIN-6; RECEPTORS, ONCOSTATIN M; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84911984873     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22739     Document Type: Article

References (43)

1. Alliot F, Marty M-C, Cambier D, Pessac B. 1996. A spontaneously immortalized mouse microglial cell line expressing CD4. Dev Brain Res 95:140-143.
2. Baker BJ, Park KW, Qin H, Ma X, Benveniste EN. 2010. IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 58:1082-1093.
3. Bauer S, Kerr BJ, Patterson PH. 2007. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8:221-232.
4. Bravo J, Heath JK. 2000. Receptor recognition by gp130 cytokines. EMBO J 19:2399-411.
5. Brivanlou AH, Darnell JE Jr. 2002. Signal transduction and the control of gene expression. Science 295:813-818.
6. Carter SL, Muller M, Manders PM, Campbell IL. 2007. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55:1728-1739.
7. Drogemuller K, Helmuth U, Brunn A, Sakowicz-Burkiewicz M, Gutmann DH, Mueller W, Deckert M, Schluter D. 2008. Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J Immunol 181:2683-2693.
8. Ellis SL, Gysbers V, Manders PM, Li W, Hofer MJ, Muller M, Campbell IL. 2010. The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1. J Immunol 185:1864-1877.
9. Ernst M, Jenkins BJ. 2004. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet 20:23-32.
10. Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grotzinger J, Rose-John S. 1997. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15:142-145.
11. Frieling JT, Sauerwein RW, Wijdenes J, Hendriks T, van der Linden CJ. 1994. Soluble IL-6 receptor in biological fluids from human origin. Cytokine 6:376-381.
12. Garbers C, Janner N, Chalaris A, Moss ML, Floss DM, Meyer D, Koch-Nolte F, Rose-John S, Scheller J. 2011. Species specificity of ADAM10 and ADAM17 proteins in IL-6 trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. J Biol Chem 286:14804-14811.
13. Gearing DP, Druck T, Huebner K, Overhauser J, Gilbert DJ, Copeland NG, Jenkins NA. 1993. The leukemia inhibitory factor receptor (LIFR) gene is located within a cluster of cytokine receptor loci on mouse chromosome 15 and human chromosome 5p12-p13. Genomics 18:148-150.
14. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, Radford J, Van Rooijen N, Campbell IL, King NJ. 2008. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 205:2319-2337.
15. Glezer I, Rivest S. 2010. Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites. Brain Behav Immun 24:695-704.
16. Ichihara M, Hara T, Kim H, Murate T, Miyajima A. 1997. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood 90:165-173.
17. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
18. Komori T, Tanaka M, Senba E, Miyajima A, Morikawa Y. 2013. Lack of oncostatin M receptor beta leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype. J Biol Chem 288:21861-21875.
19. Larrea E, Aldabe R, Gonzalez I, Segura V, Sarobe P, Echeverria I, Prieto J. 2009. Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells. J Virol 83:3298-3311.
20. Li YM, Baviello G, Vlassara H, Mitsuhashi T. 1997. Glycation products in aged thioglycollate medium enhance the elicitation of peritoneal macrophages. J Immunol Methods 201:183-188.
21. Lin HW, Levison SW. 2009. Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia. J Neurochem 111:808-818.
22. Marz P, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U. 1999. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 26:191-200.
23. Marz P, Heese K, Hock C, Golombowski S, Muller-Spahn F, Rose-John S, Otten U. 1997. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 239:29-32.
24. Milner R, Ffrench-Constant C. 1994. A developmental analysis of oligodendroglial integrins in primary cells: Changes in alpha v-associated beta subunits during differentiation. Development 120:3497-3506.
25. Misharin AV, Saber R, Perlman H. 2012. Eosinophil contamination of thioglycollate-elicited peritoneal macrophage cultures skews the functional readouts of in vitro assays. J Leukoc Biol 92:325-331.
26. Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D. 1996. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271:32635-32643.
27. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A. 2004. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39:635-644.
28. O'Brien CA, Lin SC, Bellido T, Manolagas SC. 2000. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines. J Cell Biochem 79:532-541.
29. Ransohoff RM, Perry VH. 2009. Microglial physiology: Unique stimuli, specialized responses. Annu Rev Immunol 27:119-145.
30. Repovic P, Benveniste EN. 2002. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci 22:5334-5343.
31. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
32. Rose TM, Bruce AG. 1991. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci U S A 88:8641-8645.
33. Rose TM, Lagrou MJ, Fransson I, Werelius B, Delattre O, Thomas G, de Jong PJ, Todaro GJ, Dumanski JP. 1993. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22. Genomics 17:136-140.
34. Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Bruck W, Rieckmann P. 2001. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol 60:1087-1098.
35. Schindler C, Strehlow I. 2000. Cytokines and STAT signaling. Adv Pharmacol 47:113-174.
36. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119:7-35.
37. Stalder A, Pagenstecher A, Kincaid C, Campbell IL. 1999. Analysis of gene expression by multiprobe RNase protection assay. In: Harry J, Tilson HA, editors. Neurodegeneration methods and protocols. Totowa, NJ: Human Press. pp 53-66.
38. Tamura S, Morikawa Y, Senba E. 2003. Localization of oncostatin M receptor beta in adult and developing CNS. Neuroscience 119:991-997.
39. Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A. 1999. Reconstitution of the functional mouse oncostatin M (OSM) receptor: Molecular cloning of the mouse OSM receptor beta subunit. Blood 93:804-815.
40. Turnley AM, Bartlett PF. 2000. Cytokines that signal through the leukemia inhibitory factor receptor-beta complex in the nervous system. J Neurochem 74:889-899.
41. Van Wagoner NJ, Choi C, Repovic P, Benveniste EN. 2000. Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem 75:563-575.
42. Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN. 1999. Interleukin-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 19:5236-5244.
43. Walker EC, McGregor NE, Poulton IJ, Solano M, Pompolo S, Fernandes TJ, Constable MJ, Nicholson GC, Zhang JG, Nicola NA, et al. 2010. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest 120:582-592.